CIK 0001657677 · <br>Emerging growth company
Parabilis Medicines, Inc.
Sign in to watch- Ticker
- PBLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474505725
- Phone
- 617-945-9510
- Business address
- 30 ACORN PARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140
- Former names
- FOG PHARMACEUTICALS, INC.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 244,593 shares at an average $28.29 ($6,919,551)
- 4 Open-market buy 10% owner bought 500,000 shares at $20.00 ($10,000,000)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 17,500 shares at an average $27.06 ($473,529)
- 4 Open-market buy Director bought 21,188,750 shares at $20.00 ($423,775,000)
- 4 Conversion Director acquired 14,688 shares (conversion)
- 4 Open-market buy Director bought 12,500 shares at $20.00 ($250,000)
Page 1 of 4 · 65 filings